1. Artificial intelligence (AI) increased lung nodule detection in LDCT interpretations. 2. No significant reduction in interpretation time was observed with AI assistance. 3. 911 asymptomatic individuals participated in the study. 4. Detection rates of Lung-RADS-positive nodules were 17% with AI versus 10% without. 5. Long-term clinical impacts remain uncertain with a median follow-up of 7 months. 6. Funding was provided by Coreline Soft, the AI tool's developer. 7. The study's design may not generalize across diverse clinical contexts.